SPONSORED:

House Dem chairmen to meet with progressives amid drug pricing divisions

House Dem chairmen to meet with progressives amid drug pricing divisions
© Greg Nash

Two key House Democratic committee chairmen will meet with progressive House Democrats next week amid divisions in the party over how to craft their signature legislation to lower drug prices, according to House Democratic aides.

House Energy and Commerce Committee Chairman Frank Pallone Jr.Frank Joseph PalloneHouse Democrats reintroduce road map to carbon neutrality by 2050 House Democrats criticize Texas's 'shortcomings in preparations' on winter storms House panel to probe conspiracy theories in the news MORE (D-N.J.) and House Ways and Means Committee Chairman Richard NealRichard Edmund NealProgressives won't oppose bill over limits on stimulus checks Biden administration 'evaluating and discussing' position on Trump tax returns Senate panel unanimously advances top Biden economic nominees MORE (D-Mass.) will meet with members of the Congressional Progressive Caucus next week to discuss legislation to allow Medicare to negotiate drug prices.

Lawmakers in the Progressive Caucus have been pushing for what they view as a bill that is tougher on drug companies, from Rep. Lloyd DoggettLloyd Alton DoggettHouse panel advances portion of relief package that includes ,400 checks Democrats urge repeal of business loss tax breaks in relief package Pediatrician killed in hostage situation at Texas medical center MORE (D-Texas), which would strip a company of its monopoly on a drug if it refused to negotiate the price with the government.

ADVERTISEMENT

But Speaker Nancy PelosiNancy PelosiLawmakers demand changes after National Guard troops at Capitol sickened from tainted food Andrew Yang condemns attacks against Asian Americans Congress in lockdown: Will we just 'get used to it'? MORE’s (D-Calif.) office is working on a competing plan that would use an outside arbitrator to set the price if negotiations fell through, a system that some progressives view as too weak.

The meeting could allow the powerful chairmen to discuss the differences of opinion on drafting the legislation with the progressive lawmakers.

A House Democratic aide said the chairmen would not be presenting a plan at the meeting and instead would be listening to gather input from lawmakers about how to craft legislation for Medicare to negotiate drug prices.

Lowering drug prices is one of House Democrats’ top priorities, one that Pelosi frequently touts as part of the party’s focus on kitchen table issues. But Democrats have yet to unveil their signature legislation on the topic, leading some progressives to grow impatient about the pace of action on a core priority.

Complicating the situation, Pelosi’s office is also in talks with the White House about lowering drug prices, something that some progressives also view with skepticism.

Pelosi expressed optimism about reaching a deal with President TrumpDonald TrumpTrump announces new tranche of endorsements DeSantis, Pence tied in 2024 Republican poll Lawmakers demand changes after National Guard troops at Capitol sickened from tainted food MORE on lowering drug prices in an interview with Time magazine on Tuesday.

“In our conversations, [at a] staff level, and my conversations with him I think we can find a path do that,” Pelosi said.